These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2457113)
1. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection. Harty JT; Plagemann PG J Virol; 1988 Sep; 62(9):3210-6. PubMed ID: 2457113 [TBL] [Abstract][Full Text] [Related]
2. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies. Plagemann PG; Harty JT; Even C Arch Virol; 1992; 123(1-2):89-100. PubMed ID: 1372497 [TBL] [Abstract][Full Text] [Related]
3. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Plagemann PG Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus. Harty JT; Chan SP; Plagemann PG Intervirology; 1987; 27(1):53-60. PubMed ID: 3610572 [TBL] [Abstract][Full Text] [Related]
5. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Li K; Chen Z; Plagemann P Virology; 1998 Mar; 242(2):239-45. PubMed ID: 9514969 [TBL] [Abstract][Full Text] [Related]
6. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. Coutelier JP; Van Snick J J Gen Virol; 1988 Aug; 69 ( Pt 8)():2097-100. PubMed ID: 3404124 [TBL] [Abstract][Full Text] [Related]
7. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Chen Z; Li K; Plagemann PG Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663 [TBL] [Abstract][Full Text] [Related]
8. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497 [TBL] [Abstract][Full Text] [Related]
9. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication. Harty JT; Chan SP; Contag CH; Plagemann PG J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974 [TBL] [Abstract][Full Text] [Related]
12. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus. Gómez KA; Coutelier JP; Retegui LA Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997 [TBL] [Abstract][Full Text] [Related]
13. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Cafruny WA; Plagemann PG Infect Immun; 1982 Sep; 37(3):1007-12. PubMed ID: 7129627 [TBL] [Abstract][Full Text] [Related]
14. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice. Monteyne P; Coutelier JP J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379 [TBL] [Abstract][Full Text] [Related]
15. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944 [TBL] [Abstract][Full Text] [Related]
16. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Plagemann PG; Rowland RR; Faaberg KS Arch Virol; 2002 Dec; 147(12):2327-47. PubMed ID: 12491101 [TBL] [Abstract][Full Text] [Related]
17. The murine antibody response to lactate dehydrogenase-elevating virus. Coutelier JP; Van Roost E; Lambotte P; Van Snick J J Gen Virol; 1986 Jun; 67 ( Pt 6)():1099-108. PubMed ID: 3519860 [TBL] [Abstract][Full Text] [Related]
18. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410 [TBL] [Abstract][Full Text] [Related]
19. Immunization with inactivated lactate dehydrogenase-elevating virus followed by virus infection favors the selection of hybridomas synthesizing antibodies cross-reacting with intermediate filaments and the LDV envelope protein VP3. Grossmann A; Weiland E Autoimmunity; 1991; 8(4):329-33. PubMed ID: 1932516 [TBL] [Abstract][Full Text] [Related]
20. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Cafruny WA; Plagemann PG Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]